OFI Private Equity has acquired 96.45% of artificial insemination products manufacturer IMV Technologies, giving the private equity firm a large enough shareholding to delist the business from Euronext Paris.
Unquote sister publication Private Equity Law Report looks at how sponsors can avoid distorted calculations
GP returns to the French software provider, which it owned from 2013 to 2016
Berlin-based fintech company will use the capital to grow its digital DCM platform
Szopi's founders join Supermercato24's business development and operations division